CONSYNANCE THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Oct 2022)
What this means for you
Registered since 27 Sept 2016. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86749993
- Registration number
- 5048078
- Mark type
- Stylized text
- Filed
- 08 Sept 2015
- Published for opposition
- 12 Jul 2016
- Registered
- 27 Sept 2016
- Attorney of record
- David L. Principe
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- ConSynance Therapeutics, Inc., Schnectady, NY, US
- ConSynance Therapeutics, Inc., Schnectady, NY, US
- ConSynance Therapeutics, Inc., Schnectady, NY, US
Prosecution history
- 27 Sept 2025 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 20 Oct 2022 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Oct 2022 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Oct 2022 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 20 Apr 2022 — TEAS SECTION 8 & 15 RECEIVED
- 27 Sept 2021 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Oct 2017 — REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
- 31 Oct 2017 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 30 Jun 2017 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 May 2017 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 27 Sept 2016 — REGISTERED-PRINCIPAL REGISTER
- 12 Jul 2016 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Jul 2016 — PUBLISHED FOR OPPOSITION
- 22 Jun 2016 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jun 2016 — LAW OFFICE PUBLICATION REVIEW COMPLETED